Skip to main content

Advertisement

SpringerLink
Log in

Determinants of mortality in patients with type 2 diabetes: a review

  • Published:
Reviews in Endocrine and Metabolic Disorders Aims and scope Submit manuscript

Abstract

We aimed to review and summarize the evidence from accomplished trials analyzing factors influencing mortality in patients with T2DM and to provide some recommendations for targets and treatment in the European region. The following databases were searched for relevant trials: PubMed and the Cochrane Library. Of 3.806 citations, 134 trials met our inclusion criteria. Results: The reduction in lifetime for 65 + −years-old patients having less than 10 years T2DM amounts to 1.8 years. Having T2DM for more than 10 years lifetime will be reduced by 2.7 years. However, the lifetime shortening factor of T2DM will even be stronger for 40 + −years-old patients at onset. Males will lose 11.6 years of life and 18.6 QUALYs. T2DM among females will reduce life by 14 QUALYs by 22 years. From a statistical point of view, the highest mortality rate will occur in an over 55-years-old European smoking and non-compliant diabetic woman with alcohol abuse living in a rural area with a low level of education and a low socio-economic status. Furthermore, other co-morbidities such as cardiovascular diseases, gout, and depression affect mortality. Additionally, mortality will increase with a BMI over 35 and also with a BMI under 20–25. This refers to the obesity paradox indicating a higher mortality rate among normal weight patients with T2DM compared to overweight patients with T2DM. HbA1c-levels between 6.5 % and 7 % are associated with the lowest impact on mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. WHO. Global status report on noncommunicable diseases 2014. Switzerland 2014. 298 p

  2. Aguiree F, Brown A, Cho NH, Dahlquist G, Dodd S, Dunning T, et al. IDF diabetes Atlas: sixth edition 6th ed. Guariguata L, Nolan T, Beagley J, Linnenkamp U, Jacqmain O, editors. International Diabetes Federation: Basel; 2013. 155 p.

  3. Chen YY, Lin YJ, Chong E, Chen PC, Chao TF, Chen SA, et al. The impact of diabetes mellitus and corresponding HbA1c levels on the future risks of cardiovascular disease and mortality: a representative cohort study in Taiwan. PLoS ONE. 2015;10(4):e0123116.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Roche MM, Wang PP. Sex differences in all-cause and cardiovascular mortality, hospitalization for individuals with and without diabetes, and patients with diabetes diagnosed early and late. Diabetes Care. 2013;36(9):2582–90.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Jones DA, Gallagher S, Rathod KS, Redwood S, de Belder MA, Mathur A, et al. Mortality in South Asians and Caucasians after percutaneous coronary intervention in the United Kingdom: an observational cohort study of 279,256 patients from the BCIS (British cardiovascular intervention Society) National Database. JACC Cardiovasc Interv. 2014;7(4):362–71.

    Article  PubMed  Google Scholar 

  6. Huang ES, Laiteerapong N, Liu JY, John PM, Moffet HH, Karter AJ. Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med. 2014;174(2):251–8.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Gordon-Dseagu VL, Shelton N, Mindell J. Diabetes mellitus and mortality from all-causes, cancer, cardiovascular and respiratory disease: evidence from the health Survey for England and Scottish health Survey cohorts. J Diabetes Complicat. 2014;28(6):791–7.

    Article  PubMed  Google Scholar 

  8. Chiang HH, Tseng FY, Wang CY, Chen CL, Chen YC, See TT, et al. All-cause mortality in patients with type 2 diabetes in association with achieved hemoglobin A(1c), systolic blood pressure, and low-density lipoprotein cholesterol levels. PLoS ONE. 2014;9(10):e109501.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Hanefeld M, Pistrosch F, Schulze J, Rothe U. The metabolic syndrome and cardiovascular diseases: an Update of medical treatment. J Metabolic Synd. 2014;3:160.

    Google Scholar 

  10. Cox AJ, Hugenschmidt CE, Wang PT, Hsu FC, Kenchaiah S, Daniel K, et al. Usefulness of biventricular volume as a predictor of mortality in patients with diabetes mellitus (from the diabetes heart study). Am J Cardiol. 2013;111(8):1152–8.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Fabbian F, De Giorgi A, Monesi M, Pala M, Tiseo R, Misurati E, et al. All-cause mortality and estimated renal function in type 2 diabetes mellitus outpatients: is there a relationship with the equation used? Diab Vasc Dis Res. 2015;12(1):46–52.

    Article  PubMed  Google Scholar 

  12. Grembowski D, Ralston JD, Anderson ML. Hemoglobin A1c, comorbid conditions and all-cause mortality in older patients with diabetes: a retrospective 9-year cohort study. Diabetes Res Clin Pract. 2014;106(2):373–82.

    Article  CAS  PubMed  Google Scholar 

  13. Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care. 2007;30(2):292–9.

    Article  PubMed  Google Scholar 

  14. Bot M, Pouwer F, Zuidersma M, van Melle JP, de Jonge P. Association of coexisting diabetes and depression with mortality after myocardial infarction. Diabetes Care. 2012;35(3):503–9.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Taylor KS, Heneghan CJ, Farmer AJ, Fuller AM, Adler AI, Aronson JK, et al. All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database. Diabetes Care. 2013;36(8):2366–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Sanchez Martinez M, Blanco A, Castell MV, Gutierrez Misis A, Gonzalez Montalvo JI, Zunzunegui MV, et al. Diabetes in older people: Prevalence, incidence and its association with medium- and long-term mortality from all causes. Aten Primaria. 2014;46(7):376–84.

    Article  PubMed  Google Scholar 

  17. Nanchen D, Rodondi N, Cornuz J, Hillier T, Ensrud KE, Cauley JA, et al. Mortality associated with diabetes and cardiovascular disease in older women. PLoS ONE. 2012;7(11):e48818.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Carrero JJ, de Mutsert R, Axelsson J, Dekkers OM, Jager KJ, Boeschoten EW, et al. Sex differences in the impact of diabetes on mortality in chronic dialysis patients. Nephrol Dial Transplant. 2011;26(1):270–6.

    Article  PubMed  Google Scholar 

  19. van Hateren KJ, Hendriks SH, Groenier KH, Bakker SJ, Bilo HJ, Kleefstra N, et al. Frailty and the relationship between blood pressure and mortality in elderly patients with type 2 diabetes (Zwolle Outpatient diabetes project Integrating available Care-34). J Hypertens. 2015;33(6):1162–6.

    Article  PubMed  CAS  Google Scholar 

  20. Egede LE, Lynch CP, Gebregziabher M, Hunt KJ, Echols C, Gilbert GE, et al. Differential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetes. J Gen Intern Med. 2013;28(2):208–15.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Dupre ME, Silberberg M, Willis JM, Feinglos MN. Education, glucose control, and mortality risks among U.S. older adults with diabetes. Diabetes Res Clin Pract. 2015;107(3):392–9.

    Article  PubMed  Google Scholar 

  22. Landman GW, Kleefstra N, van Hateren KJ, Gans RO, Bilo HJ, Groenier KH. Educational disparities in mortality among patients with type 2 diabetes in the Netherlands (ZODIAC-23). Neth J Med. 2013;71(2):76–80.

    CAS  PubMed  Google Scholar 

  23. Jackson CA, Jones NR, Walker JJ, Fischbacher CM, Colhoun HM, Leese GP, et al. Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland. Diabetologia. 2012;55(11):2938–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Saydah SH, Imperatore G, Beckles GL. Socioeconomic status and mortality: contribution of health care access and psychological distress among U.S. adults with diagnosed diabetes. Diabetes Care. 2013;36(1):49–55.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Conway BN, May ME, Blot WJ. Mortality among low-income African Americans and whites with diabetes. Diabetes Care. 2012;35(11):2293–9.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Zahra A, Lee EW, Sun LY, Park JH. Cardiovascular disease and diabetes mortality, and their relation to socio-economical, environmental, and health behavioural factors in worldwide view. Public Health. 2015;129(4):385–95.

    Article  CAS  PubMed  Google Scholar 

  27. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. J Am Med Assoc. 2003;290(14):1884–90.

    Article  CAS  Google Scholar 

  28. Shah BR, Victor JC, Chiu M, Tu JV, Anand SS, Austin PC, et al. Cardiovascular complications and mortality after diabetes diagnosis for South Asian and Chinese patients: a population-based cohort study. Diabetes Care. 2013;36(9):2670–6.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Jandorf S, Siersma V, Koster-Rasmussen R, de Fine ON, Waldorff FB. The impact of patients' involvement in cooking on their mortality and morbidity: a 19-year follow-up of patients diagnosed with type 2 diabetes mellitus. Scand J Prim Health Care. 2015;33(1):33–9.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Ylitalo KR, McEwen LN, Karter AJ, Lee P, Herman WH. Self-reported physical functioning and mortality among individuals with type 2 diabetes: insights from TRIAD. J Diabetes Complicat. 2013;27(6):565–9.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Kodama S, Tanaka S, Heianza Y, Fujihara K, Horikawa C, Shimano H, et al. Association between physical activity and risk of all-cause mortality and cardiovascular disease in patients with diabetes: a meta-analysis. Diabetes Care. 2013;36(2):471–9.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Moe B, Augestad LB, Nilsen TI. Diabetes severity and the role of leisure time physical exercise on cardiovascular mortality: the Nord-Trondelag health study (HUNT). Norway Cardiovasc Diabetol. 2013;12:83.

    Article  PubMed  Google Scholar 

  33. Moe B, Eilertsen E, Nilsen TI. The combined effect of leisure-time physical activity and diabetes on cardiovascular mortality: the Nord-Trondelag health (HUNT) cohort study. Norway Diabetes Care. 2013;36(3):690–5.

    Article  PubMed  Google Scholar 

  34. Burger KN, Beulens JW, van der Schouw YT, Sluijs I, Spijkerman AM, Sluik D, et al. Dietary fiber, carbohydrate quality and quantity, and mortality risk of individuals with diabetes mellitus. PLoS ONE. 2012;7(8):e43127.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Long GH, Cooper AJ, Wareham NJ, Griffin SJ, Simmons RK. Healthy behavior change and cardiovascular outcomes in newly diagnosed type 2 diabetic patients: a cohort analysis of the ADDITION-Cambridge study. Diabetes Care. 2014;37(6):1712–20.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Uusitupa M, Peltonen M, Lindstrom J, Aunola S, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, et al. Ten-year mortality and cardiovascular morbidity in the Finnish diabetes prevention study–secondary analysis of the randomized trial. PLoS ONE. 2009;4(5):e5656.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Bonds DE, Miller ME, Bergenstal RM, Buse JB, Byington RP, Cutler JA, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010;340:b4909.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Landman GW, van Hateren KJ, Kleefstra N, Groenier KH, Gans RO, Bilo HJ. The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11). Br J Gen Pract. 2010;60(572):172–5.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Miller ME, Williamson JD, Gerstein HC, Byington RP, Cushman WC, Ginsberg HN, et al. Effects of randomization to intensive glucose control on adverse events, cardiovascular disease, and mortality in older versus younger adults in the ACCORD trial. Diabetes Care. 2014;37(3):634–43.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Calles-Escandon J, Lovato LC, Simons-Morton DG, Kendall DM, Pop-Busui R, Cohen RM, et al. Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to control cardiovascular risk in diabetes (ACCORD) trial. Diabetes Care. 2010;33(4):721–7.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Wong CK, Wong WC, Wan YF, Chan AK, Chung KL, Chan FW, et al. Patient empowerment Programme in primary care reduced all-cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population-based propensity-matched cohort study. Diabetes Obes Metab. 2015;17(2):128–35.

    Article  CAS  PubMed  Google Scholar 

  42. McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care. 2012;35(9):1897–901.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, et al. The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care. 2012;35(6):1279–84.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Li Y, Lan L, Wang Y, Yang C, Tang W, Cui G, et al. Extremely cold and hot temperatures increase the risk of diabetes mortality in metropolitan areas of two Chinese cities. Environ Res. 2014;134:91–7.

    Article  CAS  PubMed  Google Scholar 

  45. Agarwal S, Cox AJ, Herrington DM, Jorgensen NW, Xu J, Freedman BI, et al. Coronary calcium score predicts cardiovascular mortality in diabetes: diabetes heart study. Diabetes Care. 2013;36(4):972–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Cox AJ, Hsu FC, Freedman BI, Herrington DM, Criqui MH, Carr JJ, et al. Contributors to mortality in high-risk diabetic patients in the diabetes heart study. Diabetes Care. 2014;37(10):2798–803.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Okin PM, Devereux RB, Lee ET, Galloway JM, Howard BV, Strong HS. Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the strong heart study. Diabetes. 2004;53(2):434–40.

    Article  CAS  PubMed  Google Scholar 

  48. Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012;126(15):1858–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Gholap NN, Mehta RL, Ng L, Davies MJ, Khunti K, Squire IB. Is admission blood glucose concentration a more powerful predictor of mortality after myocardial infarction than diabetes diagnosis? A retrospective cohort study. BMJ Open. 2012;2(5):1–9.

  50. Park BS, Yoon JS, Moon JS, Won KC, Lee HW. Predicting mortality of critically ill patients by blood glucose levels. Diabetes Metab J. 2013;37(5):385–90.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Sechterberger MK, Bosman RJ, Oudemans-van Straaten HM, Siegelaar SE, Hermanides J, Hoekstra JB, et al. The effect of diabetes mellitus on the association between measures of glycaemic control and ICU mortality: a retrospective cohort study. Crit Care. 2013;17(2):R52.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012;380(9854):1662–73.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Tsai CW, Grams ME, Inker LA, Coresh J, Selvin E. Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S. Diabetes Care. 2014;37(4):1002–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Toyama T, Furuichi K, Ninomiya T, Shimizu M, Hara A, Iwata Y, et al. The impacts of albuminuria and low eGFR on the risk of cardiovascular death, all-cause mortality, and renal events in diabetic patients: meta-analysis. PLoS ONE. 2013;8(8):e71810.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Svensson MK, Cederholm J, Eliasson B, Zethelius B, Gudbjornsdottir S. Swedish National Diabetes R. albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the Swedish National diabetes Register. Diab Vasc Dis Res. 2013;10(6):520–9.

    Article  PubMed  Google Scholar 

  56. Cox AJ, Hsu FC, Carr JJ, Freedman BI, Bowden DW. Glomerular filtration rate and albuminuria predict mortality independently from coronary artery calcified plaque in the diabetes heart study. Cardiovasc Diabetol. 2013;12:68.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Sinkeler SJ, Kwakernaak AJ, Bakker SJ, Shahinfar S, Esmatjes E, de Zeeuw D, et al. Creatinine excretion rate and mortality in type 2 diabetes and nephropathy. Diabetes Care. 2013;36(6):1489–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Osthus TB, von der Lippe N, Ribu L, Rustoen T, Leivestad T, Dammen T, et al. Health-related quality of life and all-cause mortality in patients with diabetes on dialysis. BMC Nephrol. 2012;13:78.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Sattar A, Argyropoulos C, Weissfeld L, Younas N, Fried L, Kellum JA, et al. All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients. BMC Nephrol. 2012;13:130.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Kong AP, Yang X, Luk A, Cheung KK, Ma RC, So WY, et al. Hypoglycaemia, chronic kidney disease and death in type 2 diabetes: the Hong Kong diabetes registry. BMC Endocr Disord. 2014;14:48.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Lynch CP, Gebregziabher M, Zhao Y, Hunt KJ, Egede LE. Impact of medical and psychiatric multi-morbidity on mortality in diabetes: emerging evidence. BMC Endocr Disord. 2014;14:68.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Coleman SM, Katon W, Lin E, Von Korff M. Depression and death in diabetes; 10-year follow-up of all-cause and cause-specific mortality in a diabetic cohort. Psychosomatics. 2013;54(5):428–36.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Ribe AR, Laursen TM, Sandbaek A, Charles M, Nordentoft M, Vestergaard M. Long-term mortality of persons with severe mental illness and diabetes: a population-based cohort study in Denmark. Psychol Med. 2014;44(14):3097–107.

    Article  CAS  PubMed  Google Scholar 

  64. Fedeli U, Zoppini G, Gennaro N, Saugo M. Diabetes and cancer mortality: a multifaceted association. Diabetes Res Clin Pract. 2014;106(3):e86–9.

    Article  PubMed  Google Scholar 

  65. Tseng CH. Diabetes but not insulin is associated with higher colon cancer mortality. World J Gastroenterol. 2012;18(31):4182–90.

    Article  PubMed  PubMed Central  Google Scholar 

  66. van de Poll-Franse LV, Haak HR, Coebergh JW, Janssen-Heijnen ML, Lemmens VE. Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis. Diabetologia. 2012;55(8):2163–72.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Chiou WK, Hwang JS, Hsu KH, Lin JD. Diabetes mellitus increased mortality rates more in gender-specific than in nongender-specific cancer patients: a retrospective study of 149,491 patients. Exp Diabetes Res. 2012;2012:701643.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Zhou Y, Zhang X, Gu C, Xia J. Influence of diabetes mellitus on mortality in breast cancer patients. ANZ J Surg. 2014;85:972–978.

  69. Vavallo A, Simone S, Lucarelli G, Rutigliano M, Galleggiante V, Grandaliano G, et al. Pre-existing type 2 diabetes mellitus is an independent risk factor for mortality and progression in patients with renal cell carcinoma. Medicine (Baltimore). 2014;93(27):e183.

    Article  CAS  Google Scholar 

  70. Chen ST, Hsueh C, Chiou WK, Lin JD. Disease-specific mortality and secondary primary cancer in well-differentiated thyroid cancer with type 2 diabetes mellitus. PLoS ONE. 2013;8(1):e55179.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Kiderlen M, de Glas NA, Bastiaannet E, Engels CC, van de Water W, de Craen AJ, et al. Diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysis. Ann Oncol. 2013;24(12):3011–6.

    Article  CAS  PubMed  Google Scholar 

  72. Psutka SP, Stewart SB, Boorjian SA, Lohse CM, Tollefson MK, Cheville JC, et al. Diabetes mellitus is independently associated with an increased risk of mortality in patients with clear cell renal cell carcinoma. J Urol. 2014;192(6):1620–7.

    Article  PubMed  Google Scholar 

  73. Randle RW, Ahmed S, Levine EA, Fino NF, Swett KR, Stewart JH, et al. Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2015;111(6):740–5.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Conway BN, May ME, Fischl A, Frisbee J, Han X, Blot WJ. Cause-specific mortality by race in low-income Black and White people with type 2 diabetes. Diabet Med. 2015;32(1):33–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Liu J. Impact of diabetes mellitus on pneumonia mortality in a senior population: results from the NHANES III follow-up study. J Geriatr Cardiol. 2013;10(3):267–71.

    PubMed  PubMed Central  Google Scholar 

  76. Poole CD, Halcox JP, Jenkins-Jones S, Carr ES, Schifflers MG, Ray KK, et al. Omega-3 fatty acids and mortality outcome in patients with and without type 2 diabetes after myocardial infarction: a retrospective, matched-cohort study. Clin Ther. 2013;35(1):40–51.

    Article  CAS  PubMed  Google Scholar 

  77. Logue J, Walker JJ, Leese G, Lindsay R, McKnight J, Morris A, et al. Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care. 2013;36(4):887–93.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Ma SH, Park BY, Yang JJ, Jung EJ, Yeo Y, Whang Y, et al. Interaction of body mass index and diabetes as modifiers of cardiovascular mortality in a cohort study. J Prev Med Public Health. 2012;45(6):394–401.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Murphy RA, Reinders I, Garcia ME, Eiriksdottir G, Launer LJ, Benediktsson R, et al. Adipose tissue, muscle, and function: potential mediators of associations between body weight and mortality in older adults with type 2 diabetes. Diabetes Care. 2014;37(12):3213–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Lajous M, Bijon A, Fagherazzi G, Boutron-Ruault MC, Balkau B, Clavel-Chapelon F, et al. Body mass index, diabetes, and mortality in French women: explaining away a “paradox”. Epidemiology. 2014;25(1):10–4.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Jackson CL, Yeh HC, Szklo M, Hu FB, Wang NY, Dray-Spira R, et al. Body-Mass index and all-cause mortality in US adults with and without diabetes. J Gen Intern Med. 2014;29(1):25–33.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Suemoto CK, Lebrao ML, Duarte YA, Danaei G. Effects of body mass index, abdominal obesity, and type 2 diabetes on mortality in community-dwelling elderly in Sao Paulo, Brazil: analysis of prospective data from the SABE study. J Gerontol A Biol Sci Med Sci. 2015;70(4):503–10.

    Article  PubMed  Google Scholar 

  83. Carnethon MR, De Chavez PJ, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, et al. Association of weight status with mortality in adults with incident diabetes. J Am Med Assoc. 2012;308(6):581–90.

    Article  CAS  Google Scholar 

  84. Menke A, Casagrande SS, Cowie CC. The relationship of adiposity and mortality among people with diabetes in the US general population: a prospective cohort study. BMJ Open. 2014;4(11):e005671.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Franco M, Bilal U, Ordunez P, Benet M, Morejon A, Caballero B, et al. Population-wide weight loss and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980-2010: repeated cross sectional surveys and ecological comparison of secular trends. BMJ. 2013;346:f1515.

    Article  PubMed  Google Scholar 

  86. Bodegard J, Sundstrom J, Svennblad B, Ostgren CJ, Nilsson PM, Johansson G. Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: a cohort study of 8486 primary-care patients. Diabetes Metab. 2013;39(4):306–13.

    Article  CAS  PubMed  Google Scholar 

  87. Sluik D, Boeing H, Montonen J, Pischon T, Kaaks R, Teucher B, et al. Associations between general and abdominal adiposity and mortality in individuals with diabetes mellitus. Am J Epidemiol. 2011;174(1):22–34.

    Article  PubMed  Google Scholar 

  88. Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care. 2000;23(10):1499–504.

    Article  CAS  PubMed  Google Scholar 

  89. Bozorgmanesh M, Arshi B, Sheikholeslami F, Azizi F, Hadaegh F. No obesity Paradox-BMI Incapable of Adequately Capturing the relation of obesity with all-cause mortality: an Inception diabetes cohort study. Int J Endocrinol. 2014;2014:282089.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Nayak AU, Nevill AM, Bassett P, Singh BM. Association of glycation gap with mortality and vascular complications in diabetes. Diabetes Care. 2013;36(10):3247–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Bancks MP, Odegaard AO, Pankow JS, Koh WP, Yuan JM, Gross MD, et al. Glycated hemoglobin and all-cause and cause-specific mortality in Singaporean Chinese without diagnosed diabetes: the Singapore Chinese health study. Diabetes Care. 2014;37(12):3180–7.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Sluik D, Boeing H, Montonen J, Kaaks R, Lukanova A, Sandbaek A, et al. HbA1c measured in stored erythrocytes is positively linearly associated with mortality in individuals with diabetes mellitus. PLoS ONE. 2012;7(6):e38877.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Gordon-Dseagu VL, Mindell JS, Steptoe A, Moody A, Wardle J, Demakakos P, et al. Impaired glucose metabolism among those with and without diagnosed diabetes and mortality: a cohort study using health Survey for England data. PLoS ONE. 2015;10(3):e0119882.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  94. Twito O, Ahron E, Jaffe A, Afek S, Cohen E, Granek-Catarivas M, et al. New-onset diabetes in elderly subjects: association between HbA1c levels, mortality, and coronary revascularization. Diabetes Care. 2013;36(11):3425–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Arnold LW, Wang Z. The HbA1c and all-cause mortality relationship in patients with type 2 diabetes is J-shaped: a meta-analysis of observational studies. Rev Diabet Stud. 2014;11(2):138–52.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Nicholas J, Charlton J, Dregan A, Gulliford MC. Recent HbA1c values and mortality risk in type 2 diabetes. population-based case-control study. PLoS One. 2013;8(7):e68008.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Skriver MV, Sandbaek A, Kristensen JK, Stovring H. Relationship of HbA1c variability, absolute changes in HbA1c, and all-cause mortality in type 2 diabetes: a Danish population-based prospective observational study. BMJ Open Diabetes Res Care. 2015;3(1):e000060.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Twito O, Frankel M, Nabriski D. Impact of glucose level on morbidity and mortality in elderly with diabetes and pre-diabetes. World J Diabetes. 2015;6(2):345–51.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Khunti K, Davies M, Majeed A, Thorsted BL, Wolden ML, Paul SK. Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study. Diabetes Care. 2015;38(2):316–22.

    Article  PubMed  Google Scholar 

  100. Huang CC, Weng SF, Tsai KT, Chen PJ, Lin HJ, Wang JJ, et al. Long-term mortality risk after Hyperglycemic Crisis Episodes in Geriatric patients with diabetes: A National Population-Based Cohort Study. Diabetes Care. 2015;38(5):746–51.

    Article  CAS  PubMed  Google Scholar 

  101. Viana MV, Moraes RB, Fabbrin AR, Santos MF, Torman VB, Vieira SR, et al. Contrasting effects of preexisting hyperglycemia and higher body size on hospital mortality in critically ill patients: a prospective cohort study. BMC Endocr Disord. 2014;14:50.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Chen KH, Shao YY, Lin ZZ, Yeh YC, Shau WY, Kuo RN, et al. Type 2 diabetes mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colon cancer. Oncologist. 2014;19(9):951–8.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Charlton J, Latinovic R, Gulliford MC. Explaining the decline in early mortality in men and women with type 2 diabetes: a population-based cohort study. Diabetes Care. 2008;31(9):1761–6.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Afghahi H, Svensson MK, Pirouzifard M, Eliasson B, Svensson AM. Blood pressure level and risk of major cardiovascular events and all-cause of mortality in patients with type 2 diabetes and renal impairment: an observational study from the Swedish National Diabetes Register. Diabetologia. 2015;58(6):1203–11.

    Article  CAS  PubMed  Google Scholar 

  105. Vamos EP, Harris M, Millett C, Pape UJ, Khunti K, Curcin V, et al. Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study. BMJ. 2012;345:e5567.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Miselli MA, Nora ED, Passaro A, Tomasi F, Zuliani G. Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study. Cardiovasc Diabetol. 2014;13:135.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  107. Xu Y, Zhu J, Gao L, Liu Y, Shen J, Shen C, et al. Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysis. PLoS ONE. 2013;8(10):e78206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Kengne AP, Czernichow S, Hamer M, Batty GD, Stamatakis E. Anaemia, haemoglobin level and cause-specific mortality in people with and without diabetes. PLoS ONE. 2012;7(8):e41875.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Potier L, Roussel R, Labreuche J, Marre M, Cacoub P, Rother J, et al. Interaction between diabetes and a high ankle-brachial index on mortality risk. Eur J Prev Cardiol. 2015;22(5):615–21.

    Article  PubMed  Google Scholar 

  110. Muraleedharan V, Marsh H, Kapoor D, Channer KS, Jones TH. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes. Eur J Endocrinol. 2013;169(6):725–33.

    Article  CAS  PubMed  Google Scholar 

  111. Pikkemaat M, Melander O, Molstad S, Garberg G, Bostrom KB. C-peptide concentration, mortality and vascular complications in people with type 2 diabetes. The Skaraborg Diabetes Register Diabet Med. 2015;32(1):85–9.

    Article  CAS  PubMed  Google Scholar 

  112. Lowe G, Woodward M, Hillis G, Rumley A, Li Q, Harrap S, et al. Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study. Diabetes. 2014;63(3):1115–23.

    Article  CAS  PubMed  Google Scholar 

  113. Ofstad AP, Gullestad L, Orvik E, Aakhus S, Endresen K, Ueland T, et al. Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Baerum cardiovascular diabetes (ABCD) cohort study. Cardiovasc Diabetol. 2013;12:126.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  114. Bruno G, Landi A, Barutta F, Ghezzo G, Baldin C, Spadafora L, et al. N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study. Diabetes Care. 2013;36(9):2677–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Cheung CL, Lam KS, Cheung BM. Serum beta-2 microglobulin predicts mortality in people with diabetes. Eur J Endocrinol. 2013;169(1):1–7.

    Article  CAS  PubMed  Google Scholar 

  116. Cavusoglu E, Marmur JD, Chhabra S, Hojjati MR, Yanamadala S, Chopra V, et al. Elevated baseline plasma phospholipid protein (PLTP) levels are an independent predictor of long-term all-cause mortality in patients with diabetes mellitus and known or suspected coronary artery disease. Atherosclerosis. 2015;239(2):503–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  117. Lee JE, Gohda T, Walker WH, Skupien J, Smiles AM, Holak RR, et al. Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1. PLoS ONE. 2013;8(3):e58007.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Drion I, Kleefstra N, Landman GW, Alkhalaf A, Struck J, Groenier KH, et al. Plasma COOH-terminal proendothelin-1: a marker of fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in type 2 diabetes? (ZODIAC-29). Diabetes Care. 2012;35(11):2354–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  119. van Hateren KJ, Landman GW, Kleefstra N, Groenier KH, Struck J, Navis GJ, et al. The midregional fragment of pro-A-type natriuretic peptide, blood pressure, and mortality in a prospective cohort study of patients with type 2 diabetes (ZODIAC-25). Diabetes Care. 2013;36(5):1347–52.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  120. Broedbaek K, Siersma V, Henriksen T, Weimann A, Petersen M, Andersen JT, et al. Association between urinary markers of nucleic acid oxidation and mortality in type 2 diabetes: a population-based cohort study. Diabetes Care. 2013;36(3):669–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Landman GW, van Vliet-Ostaptchouk JV, Kleefstra N, van Hateren KJ, Drion I, Groenier KH, et al. Association between 9p21 genetic variants and mortality risk in a prospective cohort of patients with type 2 diabetes (ZODIAC-15). Cardiovasc Diabetol. 2012;11:138.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Prudente S, Shah H, Bailetti D, Pezzolesi M, Buranasupkajorn P, Mercuri L, et al. Genetic Variant at the GLUL Locus predicts all-cause mortality in patients with type 2 diabetes. Diabetes. 2015;64(7):2658–63.

    Article  CAS  PubMed  Google Scholar 

  123. Cox AJ, Hsu FC, Ng MC, Langefeld CD, Freedman BI, Carr JJ, et al. Genetic risk score associations with cardiovascular disease and mortality in the diabetes heart study. Diabetes Care. 2014;37(4):1157–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  124. Armstrong MJ, Sigal RJ, Arena R, Hauer TL, Austford LD, Aggarwal S, et al. Cardiac rehabilitation completion is associated with reduced mortality in patients with diabetes and coronary artery disease. Diabetologia. 2015;58(4):691–8.

    Article  PubMed  Google Scholar 

  125. Tzoulaki I, Molokhia M, Curcin V, Little MP, Millett CJ, Ng A, et al. Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. BMJ. 2009;339:b4731.

    Article  PubMed  PubMed Central  Google Scholar 

  126. Mogensen UM, Andersson C, Fosbol EL, Schramm TK, Vaag A, Scheller NM, et al. Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality–a retrospective nationwide study. Diabetes Res Clin Pract. 2015;107(1):104–12.

    Article  CAS  PubMed  Google Scholar 

  127. Margel D, Urbach DR, Lipscombe LL, Bell CM, Kulkarni G, Austin PC, et al. Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes. J Clin Oncol. 2013;31(25):3069–75.

    Article  CAS  PubMed  Google Scholar 

  128. Bannister CA, Holden SE, Jenkins-Jones S, Morgan CL, Halcox JP, Schernthaner G, et al. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab. 2014;16(11):1165–73.

    Article  CAS  PubMed  Google Scholar 

  129. Christiansen C, Johansen M, Christensen S, O'Brien JM, Tonnesen E, Sorensen H. Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study. Crit Care. 2013;17(5):R192.

    Article  PubMed  PubMed Central  Google Scholar 

  130. Vissers PA, Cardwell CR, van de Poll-Franse LV, Young IS, Pouwer F, Murray LJ. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes. Breast Cancer Res Treat. 2015;150(2):427–37.

    Article  CAS  PubMed  Google Scholar 

  131. Gu Y, Wang C, Zheng Y, Hou X, Mo Y, Yu W, et al. Cancer incidence and mortality in patients with type 2 diabetes treated with human insulin: a cohort study in Shanghai. PLoS ONE. 2013;8(1):e53411.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  132. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26(7):650–61.

    Article  CAS  PubMed  Google Scholar 

  133. Holden SE, Jenkins-Jones S, Morgan CL, Schernthaner G, Currie CJ. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer. Diabetes Obes Metab. 2015;17(4):350–62.

    Article  CAS  PubMed  Google Scholar 

  134. Currie CJ, Poole CD, Evans M, Peters JR, Morgan CL. Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes. J Clin Endocrinol Metab. 2013;98(2):668–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  135. Roumie CL, Greevy RA, Grijalva CG, Hung AM, Liu X, Murff HJ, et al. Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes. J Am Med Assoc. 2014;311(22):2288–96.

    Article  CAS  Google Scholar 

  136. Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. role of kinins and angiotensin II type 2 receptors. J Clin Invest. 1997;99(8):1926–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  137. Rison RA, Kidd MR, Koch CA. The CARE (CAse REport) guidelines and the standardization of case reports. J Med Case Rep. 2013;7:261.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Health Sciences/Public Health, Faculty of Medicine, TUD, Fetscherstraße 74, D-01307, Dresden, Germany

    Jana Engelmann, Ulf Manuwald, Constanze Rubach, Joachim Kugler & Ulrike Rothe

  2. Medical Clinic III, University Clinic, Faculty of Medicine, TUD, Fetscherstraße 74, D-01307, Dresden, Germany

    Andreas L. Birkenfeld

  3. Study Center Prof. Hanefeld, Research for Metabolic Vascular Syndrome, GWT-TUD GmbH, Fiedlerstraße 34, D-01307, Dresden, Germany

    Andreas L. Birkenfeld & Markolf Hanefeld

Authors
  1. Jana Engelmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulf Manuwald
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Constanze Rubach
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joachim Kugler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andreas L. Birkenfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Markolf Hanefeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ulrike Rothe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrike Rothe.

Ethics declarations

Conflict of Interest

All authors have declared that they have no conflicts related to this work.

Additional information

Jana Engelmann and Ulf Manuwald contributed equally.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Engelmann, J., Manuwald, U., Rubach, C. et al. Determinants of mortality in patients with type 2 diabetes: a review. Rev Endocr Metab Disord 17, 129–137 (2016). https://doi.org/10.1007/s11154-016-9349-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11154-016-9349-0

Keywords

Search

Navigation